David K. O’Brien

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

Claudia Allemani, Tomohiro Matsuda, V Di Carlo et al. · The Lancet · 2018 · 5.9K citations · Full text

Epidemiology, Cancer Epidemiology, Medicine +11

Type IV pili‐dependent gliding motility in the Gram‐positive pathogen <i>Clostridium perfringens</i> and other Clostridia

John Varga, Van Hoa Nguyen, David K. O’Brien et al. · Molecular Microbiology · 2006 · 171 citations · Full text

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2)

M Matz, Michel P. Coleman, Milena Sant et al. · Gynecologic Oncology · 2016 · 154 citations · Full text

International Survival Comparisons, Cancer Epidemiology, Medicine +9

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)

M Matz, Michel P. Coleman, Helena Carreira et al. · Gynecologic Oncology · 2016 · 131 citations · Full text

Ovarian Cancer Survival, Gynecological Surgery, Medicine +8

Effects of <i>Clostridium perfringens</i> Alpha-Toxin (PLC) and Perfringolysin O (PFO) on Cytotoxicity to Macrophages, on Escape from the Phagosomes of Macrophages, and on Persistence of <i>C. perfringens</i> in Host Tissues

David K. O’Brien, Stephen B. Melville · Infection and Immunity · 2004 · 127 citations · Full text

Inflammation, Microbial Toxin, Membrane-active Toxins +15